Lobbying activity
Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 156 filings
Top spenders & firms Spend by issue Political contributions Revolving door
1A
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
Q1
WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)
Q1
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
Q1
TWINLOGIC STRATEGIES, LLP for ASSOCIATION FOR ACCESSIBLE MEDICINES
Q1
ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
Q1
AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) for AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)
Q1
GUIDEWELL MUTUAL HOLDING CORPORATION for GUIDEWELL MUTUAL HOLDING CORPORATION
Q1
BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. for BLUE CROSS AND BLUE SHIELD OF FLORIDA INC
Q1
T1INTERNATIONAL USA for T1INTERNATIONAL USA
Q1
COVINGTON & BURLING LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC
Q1
BCBSM, INC. for BCBSM INC
Q1
BLUE CROSS BLUE SHIELD OF MICHIGAN for BLUE CROSS BLUE SHIELD OF MICHIGAN
Q1
AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA) for AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA)
Q1
BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. for BLUE CROSS AND BLUE SHIELD OF KANSAS INC
Q1
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
Q1
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
Q1
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Q1
BLUE CROSS AND BLUE SHIELD ASSOCIATION for BLUE CROSS AND BLUE SHIELD ASSOCIATION
Q1
AARP for AARP
Q1
NOVARTIS for NOVARTIS
Q1
CROSSROADS STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Q1
TIBER CREEK GROUP for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY)
Q1
BLUECROSS BLUESHIELD OF TENNESSEE for BLUECROSS BLUESHIELD OF TENNESSEE
Q1
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING
Q1
S-3 GROUP for VIATRIS (MYLAN, INC)